Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Platelets
Animal and experimental models
Biochemistry and signal transduction
Inherited and acquired platelet disorders
Integrins and other adhesive proteins
Interaction with other cells
Megakaryocytes and thrombopoiesis
Other blood cells
Other glycoproteins
Other platelets
Physiology and pharmacology
Platelet activation markers
Platelet (function) tests
Procoagulant and fibrinolytic activity
Receptors for primary agonists
Secretion and protein trafficking
Structural biology and drug design
A modified ELISA procedure for platelet factor 4 with decreased heparin sensitivity
Grimaux M., Caron N., Quignon V., Woodhams B.
A new platelet activation marker specific for activated integrin alpha2beta1: monoclonal antibody IAC-1
Schoolmeester A., Vanhoorelbeke K., Lecut C., Heemskerk J. M. W., Hoylarts M. F., Deckmyn H.
Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Connor D. E., Joseph J. E., Baron D. W., Muller D. W., Roy P., Wilson S. W., Ma D. D. F.
Comparison of two methods to assess platelet activation during and after CABG
Gruenewald M., Goedje O., Gallmeier G. U., Ruf A., Reitenauer M., Gruenewald A., Konegen A., Griesshammer M.
Effects of cardiopulmonary bypass on platelet activation markers
Gonçalves L., Fraga M., Oliveira G., Castelo-Branco S., Pereira R., Cunha-Ribeiro L. M.
Effects of proteasome inhibitors on alpha-granule secretion and microparticle formation during thrombin-induced platelet activation
Ostrowska H., Manur M., Ostrowska J. K.
Enhanced in vivo platelet activation in patients with peripheral arterial disease, and differences between intermittent claudication and critical limb ischemia
Ford I., Cassar K., Mitchell L., Greaves M., Bachoo P., Brittenden J.
Flow cytometry analysis of platelet activation throughout normal gestation and puerperium
Bermejo E., Sanchez-Luceros A., Alberto M. F., Meschengieser S. S., Lazzari M. A.
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Michelson A. D., Krueger L. A., Furman M. I., Barnard M. R., Fox M. L., Frelinger A. L.
Human platelet microparticles shedding is independent of the Cdc42/Rac1/PAK Pathway
Vidal C., Bouziane A., Picard F., Weber S., Fontenay M.
Immuno-phenotypic platelet characteristics distinguish high vs. low risk patients for thrombosis after stent implantation under thienopyridin plus aspirin treatment
Teuma X., Barragan P., Poncelet P., Moulard M.
Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Allen G., Wolberg A.S., Oliver J.A., Hoffman M., Roberts H.R., Monroe D.M.
Increase in platelet VEGF release in early breast cancer
Hewitt J., Temple I., Mcdowell G., Kirwan C., Burton I. E., Bundred N. J., Byrne G. J.
Influence of platelet glycoprotein IIIa PlA polymorphism on mean platelet volume and vWF after coronary stent implantation
Kottmann T., Piper C., Farr M., Wiemer M., Schmidt M., Kleesiek K., Horstkotte D.
Loss of stability of the baseline state and the coagulation triggering: a mathematical modeling study
Khanin M. A., Rakov D. V.
Lower activation of circulating platelets after implantation of Toyobo LVAS was associated with lower incidence of thromboembolism: a comparison with Novacor LVAS
Murasaki S., Murasaki K., Tanoue K., Kawana M., Kasanuki H.
Plasma P selectin must be measured in a citrated sample, not in serum
Caine G., Bareford D., Lip G. Y. H., Blann A.
Platelet activation and platelet VASP phosphorylation in mice with streptozotocin-induced diabetes mellitus – association with endothelial dysfunction and reduced nitric oxide bioactivity
Schäfer A., Alp N. J., Cai S., Eigenthaler M., Bauersachs J., Walter U., Channon K. M.
Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Ozeki Y., Uehata S., Tanaka A., Namba M., Kasuga N., Saito S., Kawarabayashi T., Nomura S.
Real-time visualization of platelet shape changes occurring in response to their adhesion on immobilized type I collagen or von willebrand factor under controlled blood flow conditions
Tamura N., Goto S., Ishida H., Tanabe T., Handa S.
Regulation of GPVI-mediated platelet procoagulant response and degranulation
Appleby J. A., Farndale R. W., Goodall A. H.
Soluble platelet GPV: a new marker of thrombosis status
Shao B., Liu C., Yang X., Lv M., Bai X., Zhai W., Cheng X., Tang H., Yang X., Shi B., Ruan C.
The G allele of IL-6–174G/C polymorphism is a risk factor for restenosis after coronary stent implantation by increased inflammation and platelet activation
Kottmann T., Piper C., Farr M., Wiemer M., Baller D., Kleesiek K., Horstkotte D.
The influence of change of cell surfaces on aggregation function of blood
Mirsamatova G.